Search clinical trials for: Abrupt Clopidogrel Interruption

Total 1614 results

Xijing Hospital

Recruiting

LAAO Versus NOAC in Patients With AF and PCI

Atrial Fibrillation | Percutaneous Coronary Intervention

China
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; British Heart Foundation

Completed

Healthy Volunteer Study of Clopidogrel and Rifampicin

Coronary Artery Disease

United Kingdom
MemorialCare Health System
Memorial Medical Center Foundation

Completed

Pilot Study on Pairing Sedation Strategies and Weaning

Acute Respiratory Failure

United States
Coherex Medical

Terminated

WAVECREST Post Market Clinical Follow-Up (PMCF) Study

Non-valvular Atrial Fibrillation

Belgium
Brigham and Women's Hospital

Completed

Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data

Antiplatelet

United States
University Medical Centre Ljubljana

Completed

Antiplatelet Therapy After Cardiac Arrest

Cardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)

Slovenia
Sanofi
Bristol-Myers Squibb

Completed

Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation (CLARINET)

Heart Defects, Congenital

France, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Sweden, India, Malaysia, Singapore, Taiwan, Belgium, Mexico, Argentina, Denmark, Egypt, Finland, Hungary, Israel, Norway, Korea, Republic of, Hong Kong and more
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Clopidogrel Tablets Under Fed Condition

Healthy

India
University of Texas at Austin

Unknown

Interrupting Prolonged Sitting With Periodic Interval Exercise: Effect on Postprandial Lipemia

Hypertriglyceridemia | Sedentary Behavior

United States
University of California, San Francisco
Novartis

Completed

Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid

Osteoporosis

United States, Germany
Ottawa Heart Institute Research Corporation
Bristol-Myers Squibb; Sanofi

Completed

Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial) (CASCADE)

Atherosclerosis

Canada
Vanderbilt University Medical Center

Withdrawn

Causes of Health Disparities in African Americans With Coronary Artery Disease on Clopidogrel

Coronary Artery Disease

United States
Jiangsu vcare pharmaceutical technology co., LTD

Completed

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

Coronary Artery Disease | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors

China
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Completed

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk (RAPID MANAGE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada
Lene Holmvang

Completed

Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI (TAILOR)

Coronary Artery Disease | Percutaneous Coronary Intervention | Acute Coronary Syndromes

Denmark
University of North Carolina, Chapel Hill
Laboratory Corporation of America; Kerr Drug

Completed

Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy

Myocardial Infarction | Stroke | Transient Ischemic Attack

United States
Beijing Anzhen Hospital

Recruiting

Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)

Angina, Stable | Acute Coronary Syndrome | Drug-Eluting Stents | Genotype

China
AstraZeneca

Withdrawn

A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patient

Coronary Heart Disease
Sanofi
Bristol-Myers Squibb

Completed

Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function

Peripheral Arterial Disease

Hungary
Seoul National University Hospital

Completed

The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers

Healthy

Korea, Republic of
Novartis Pharmaceuticals

Completed

A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years

Postmenopausal Osteoporosis

Turkey
Turku University Hospital
Novartis; Academy of Finland; Stryker Nordic

Completed

Efficacy of Zoledronic Acid in Enhancement of Early Stability of Cementless Primary Hip Prosthesis

Hip Osteoarthritis

Finland
Novartis

Completed

Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma

Treatment of Bone Metastases

China
Yonsei University

Recruiting

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Atrial Fibrillation

Korea, Republic of
Ping-Yen Liu

Unknown

Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients (APROVE-CKD)

Chronic Kidney Disease | Acute Coronary Syndrome | End-Stage Renal Disease

Taiwan
National University of Singapore

Active, not recruiting

Youth Outlook on Life Opportunities Study

Anxiety | Educational Problems | Marriage Age | Childbearing, Delayed | Age Related Female Infertility

Singapore
Brigham and Women's Hospital

Completed

Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data

Antiplatelet

United States
HK inno.N Corporation

Completed

Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

Healthy

Korea, Republic of
First Affiliated Hospital of Harbin Medical University

Unknown

Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD

Platelet Reactivity

China
University Hospital, Bordeaux
Ministry for Health and Solidarity, France

Completed

Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous (CLOPUS)

Systemic Lupus Erythematous

France
Mylan Pharmaceuticals Inc

Completed

Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

Healthy

United States
Novo Nordisk A/S

Terminated

Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding

Healthy | Haemostasis

United States
Creighton University

Withdrawn

Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents

Coronary Artery Disease

United States
Sanofi

Completed

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Arteriosclerosis

France, Canada, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United States, Turkey, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finlan... and more
Sanofi

Completed

Mixed Antagonist of Serotonin for Claudication Optimal Therapy (MASCOT)

Intermittent Claudication

United States, Canada, Russian Federation, Ukraine, Germany, Sweden, Belgium, Czech Republic, Mexico
Seung-Jung Park
CardioVascular Research Foundation, Korea

Active, not recruiting

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS LATE)

Coronary Disease | Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer (TRAPEZE)

Pain

France
The Cleveland Clinic
Novartis Pharmaceuticals

Completed

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

Osteoporosis

United States
Washington University School of Medicine
Novartis Pharmaceuticals

Terminated

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Uterine Cervical Neoplasms

United States
Roswell Park Cancer Institute

Terminated

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

Multiple Myeloma and Plasma Cell Neoplasm

United States
Jules Desmeules

Terminated

Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients (IMPACT/R)

Hiv

Switzerland
Ain Shams Maternity Hospital

Unknown

Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSI

Female , Infertility

Egypt
AstraZeneca

Withdrawn

Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients (PAD)

Intermittent Claudication | Peripheral Artery Disease | Vascular Disease | Arterial Occlusion Disease | Ankle Brachial Index (0.9 or Less)
Shenyang Northern Hospital

Not yet recruiting

Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI

Rivaroxaban
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

Healthy

United States
The First Affiliated Hospital with Nanjing Medical...

Unknown

OPTImal Management of Antithrombotic Agents: OPTIMA-5

Acute Coronary Syndrome (ACS)

China
Taipei City Hospital

Completed

Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)

Stable Angina

Taiwan
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Withdrawn

Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients (PANDDA)

Diabetes

Canada
Samsung Medical Center

Unknown

Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE) (SMART-DATE)

Acute Coronary Syndrome

Korea, Republic of

Search clinical trials for: Abrupt Clopidogrel Interruption

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations